Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) EBIT: 2009-2025

Historic EBIT for Prestige Consumer Healthcare (PBH) over the last 17 years, with Mar 2025 value amounting to $336.8 million.

  • Prestige Consumer Healthcare's EBIT fell 5.54% to $79.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $331.8 million, marking a year-over-year increase of 1.98%. This contributed to the annual value of $336.8 million for FY2025, which is 1.65% down from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported EBIT of $336.8 million as of FY2025, which was down 1.65% from $342.4 million recorded in FY2024.
  • Prestige Consumer Healthcare's 5-year EBIT high stood at $342.4 million for FY2024, and its period low was -$22.4 million during FY2023.
  • Moreover, its 3-year median value for EBIT was $336.8 million (2025), whereas its average is $218.9 million.
  • Per our database at Business Quant, Prestige Consumer Healthcare's EBIT plummeted by 106.79% in 2023 and then surged by 1,627.68% in 2024.
  • Yearly analysis of 5 years shows Prestige Consumer Healthcare's EBIT stood at $297.4 million in 2021, then increased by 10.93% to $329.9 million in 2022, then slumped by 106.79% to -$22.4 million in 2023, then spiked by 1,627.68% to $342.4 million in 2024, then decreased by 1.65% to $336.8 million in 2025.